首页> 外文期刊>Obstetrics and Gynecology International >The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds
【24h】

The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds

机译:HPV细胞反式激活子Brn-3a可用于预测发达国家和发展中国家的宫颈腺癌和鳞状癌癌前病变

获取原文
           

摘要

The cellular transactivator Brn-3a has previously been shown to be expressed at elevated levels in the cervix of women with squamous cell carcinoma of the cervix (SCC) and to activate the expression of HPV E6 mRNA. In this study, we show that common and rare cervical precancer lesions, including those of adenocarcinoma (AC), which are usually difficult to diagnose using classical procedures, also expressed high levels of Brn-3a and can be diagnosed by measuring the levels of Brn-3a and E6 mRNAs.
机译:先前已经证明,细胞反式激活因子Brn-3a在宫颈鳞状细胞癌(SCC)妇女的子宫颈中以高水平表达,并能激活HPV E6 mRNA的表达。在这项研究中,我们表明常见的和罕见的子宫颈癌前病变,包括腺癌(AC),通常难以通过经典手术进行诊断,也表达高水平的Brn-3a,并且可以通过测量Brn的水平进行诊断-3a和E6 mRNA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号